drugset / Trial / NCT02349685
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
RandomizedParallel-groupOpen-labelTreatment
Summary
As increasing the antibiotics resistance, the effectiveness of traditional Helicobacter pylori (H. pylori) therapies has been declined coincidently. In this study, the investigators evaluated the efficacy of H. pylori eradication between a personalized therapy for H. pylori infection based on the results of antibiotics resistance by using H. pylori culture and minimal inhibitory concentration (MIC) and the traditional 2nd rescue regimens, and the investigators analyzed the prevalence of the antibiotic resistance after 1st eradication of H. pylori in the tailored therapy group.
Timeline
- Start
- 2010-01
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Tetracycline | Unknown | 500 mg | — |
| Subject | tripotassium dicitrate bismuthate | Unknown | 300 mg | — |
| Background | Esomeprazole | Small molecule | — | — |